In the field of weight loss, Tirzepatide has shown great promise as a pharmacological agent. Targeting various pathways involved in glucose metabolism and weight management, it is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist. Clinical investigations have demonstrated that Tirzepatide has promising weight loss potential, making it …
Read More »